Nidan Laboratories and Healthcare Limited

Nidan Laboratories and Healthcare Limited (NIDAN) is a micro-cap Healthcare company valued at ₹18 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move

Nidan Laboratories and Healthcare Limited last traded at ₹13.55, modestly up 1.12% on the day.

Recent developments

2026-09-07: The DocStoX score increased to 4.7, but the verdict remained 'avoid' due to weak earnings growth and declining profits. 2026-06-30: Promoter holding stood at 57.04%, down 14.2% over the last three years, indicating reduced confidence.

Financial performance

The company's revenue grew 4.1% annually but fell 11.2% in the latest quarter compared to the same quarter a year earlier. Net profit dropped 23.7% annually and plunged 92.0% in the latest quarter, with margins shrinking 2.2 percentage points to 5.9%. Returns remain low, with return on equity at 2.5% and return on capital employed at 6.0%.

Valuation multiples

The stock trades at 12.6 times earnings, a discount to the Healthcare median of 32.0, 0.26 times book value.

Things to watch

The company's net profit has declined for five years, with a 24.7% annualized drop in the last three years. The latest quarter showed a sharp drop in net profit, with no earnings reported. Promoter holdings have decreased, which may signal reduced confidence in the business.

Where it stands

The DocStoX verdict of avoid follows from weak earnings growth and declining profits, despite a relatively safe balance sheet. The most critical factor is the sharp drop in net profit in the latest quarter, which highlights ongoing challenges in profitability.

Summarised by DocStoX's model on 2026-09-08 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.